| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.1M | +204.1% |
| Cost of Revenue | $3.1M | +769.3% |
| Gross Profit | $946K | -3.5% |
| R&D Expense | $756K | +10.0% |
| SG&A Expense | $1.7M | -10.3% |
| Income Tax | $0 | — |
| Net Income | -$1.3M | -116.3% |
| EPS (Basic) | -$0.08 | -114.5% |
| EPS (Diluted) | -$0.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | +35.6% |
| Current Assets | $38.1M | +41.1% |
| Total Assets | $38.2M | +40.9% |
| Current Liabilities | $4.2M | +332.8% |
| Stockholders' Equity | $34.0M | +29.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | +0.9% |
| Capital Expenditures | $3K | -49.8% |
| Investing Cash Flow | -$2.6M | -1515.2% |
| Financing Cash Flow | $6.7M | +148.6% |
| Free Cash Flow | -$3.5M | +1.0% |
| -114.5% |